Featured

An interview with Professor John Read who joins us to discuss the UK licensing of esketamine nasal spray (Spravato) for so-called ‘Treatment Resistant Depression’. John led a group of 12 academics and professionals who wrote to the UK regulator expressing concerns.

On October 10th, 2018, World Mental Health Day, The Lancet Commission on Global Mental Health and Sustainable Development published a report outlining a proposal to “scale up” mental health care globally. In this podcast series, we discuss the implications.

I remember the time when, six years ago, after almost two decades of treatment under mental health services, my life didn’t seem worth living and I believed that it was only a matter of time before I would finally succeed in taking my own life.

In almost any other situation, pinning people down and injecting them would be cause for investigations and criminal charges. The perpetrators would be seen as aggressors. Those who fought back would be seen as courageous. Those who accepted their fate would be understood. We would draw a line.

We hold the view that a caring and morally mindful society must better safeguard children by allowing them to develop their unique personalities and behaviours without the use of a first response to prescribe psychiatric drugs for behavioural difficulties.